Motivational Interviewing for HIV-Positive Youth in Thailand
Motivational Interviewing for HIV-Positive Youth in Thailand
Motivational Interviewing for HIV-Positive Youth in Thailand
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Motivational</strong> <strong>Interview<strong>in</strong>g</strong><br />
<strong>for</strong><br />
<strong>HIV</strong>-<strong>Positive</strong> <strong>Youth</strong> <strong>in</strong> <strong>Thailand</strong><br />
Chokechai Rongkavilit, MD<br />
Children’s Hospital of Michigan<br />
Wayne State University School of Medic<strong>in</strong>e<br />
Detroit, MI, USA
Health risk behaviors <strong>in</strong> <strong>HIV</strong>+ Thai youth<br />
Survey: 70 <strong>HIV</strong>+ Thai youth aged 16-24 years<br />
In past 30 days<br />
• Two-thirds were sexually active<br />
• Half reported <strong>in</strong>consistent condom use<br />
• 25% reported alcohol use<br />
• 47% of males had sex with <strong>HIV</strong>-unknown partners and 1/3 did<br />
not disclose <strong>HIV</strong> status to partners<br />
• 20% reported
<strong>Motivational</strong> <strong>Interview<strong>in</strong>g</strong> <strong>in</strong> <strong>HIV</strong>+ Thai youth<br />
(Thai Healthy Choices)
Objective:<br />
• To evaluate 4-session MI <strong>in</strong>tervention to improve risk<br />
behaviors among <strong>HIV</strong>+ Thai youth 16-25 years<br />
▫ Condom use<br />
▫ Alcohol use<br />
<strong>HIV</strong>-NAT<br />
Bangkok<br />
Wayne State<br />
University<br />
▫ Adherence to <strong>HIV</strong> treatment<br />
City<br />
University<br />
of New York
Adaptation<br />
Thai Healthy Choices<br />
• Step I: Translation of Healthy Choices U.S. manual<br />
• Step II: Group discussion to review/modify manual<br />
• Step III: Counselor tra<strong>in</strong><strong>in</strong>g<br />
• Step IV: Pilot-test<strong>in</strong>g Healthy Choices <strong>in</strong> 11 <strong>HIV</strong>+ youth<br />
Feasibility Test<strong>in</strong>g<br />
• Step V: Pilot randomized trial <strong>in</strong> 110 <strong>HIV</strong>+ youth<br />
▫ 55 <strong>in</strong> Healthy Choices vs. 55 <strong>in</strong> Control<br />
▫ Assessment of behavior changes be<strong>for</strong>e, 1 month and 6<br />
months after <strong>in</strong>tervention
Group Discussion<br />
1. <strong>HIV</strong>+ youth (2 males, 2 females, 1 transgender)<br />
2. Health providers (1 MD, 1 nurse, 2 counselors, 1 peer<br />
advocate)<br />
Discussions focus on<br />
• How helpful/suitable is MI <strong>for</strong> Thai youth?<br />
• Role of peer, family and Buddhism and applicability <strong>in</strong> MI<br />
• Modification needed to <strong>in</strong>crease relevance <strong>for</strong> Thai youth?
Group Discussion<br />
<strong>HIV</strong>+ <strong>Youth</strong> Providers<br />
MI is appropriate, applicable and promis<strong>in</strong>g<br />
MI sessions must be flexible enough <strong>for</strong> youth to attend<br />
4 sessions might not be enough to affect behavior change<br />
Peer important <strong>for</strong> urban youth;<br />
family important <strong>for</strong> rural youth<br />
Buddhism is not relevant either to<br />
youth or MI<br />
Family is an important factor <strong>for</strong><br />
youth (collectivist society)<br />
Buddhist doctr<strong>in</strong>e can be applied <strong>in</strong><br />
MI
Pilot Test<strong>in</strong>g of MI<br />
• 11 <strong>HIV</strong>+ Thai youth: 5 men (4 homosexuals) and 6 women (1 bisexual)<br />
• 6 were on <strong>HIV</strong> medications.<br />
• 10 (91%) completed 4 MI sessions and 1-mo post-<strong>in</strong>tervention F/U<br />
• <strong>Youth</strong> reported be<strong>in</strong>g com<strong>for</strong>table talk<strong>in</strong>g with counselor at the scale<br />
of 9.8 out of 10.<br />
• Over half wanted more contacts with counselor (based on phone calls<br />
from youth between sessions).<br />
Rongkavilit, C. J Assoc Nurse AIDS Care 2012; <strong>in</strong> press
Pilot Randomized Trial <strong>in</strong> <strong>HIV</strong>+ Thai <strong>Youth</strong> (16-25 y)<br />
4 sessions of MI<br />
(1,2, 6, 12 weeks)<br />
114 approached<br />
110 enrolled<br />
4 sessions of Health Education<br />
(1,2, 6, 12 weeks)<br />
50/55 (91%) attended ≥3 sessions 46/53 (87%) attended ≥3 sessions<br />
Both groups were followed at 1 & 6 mo <strong>for</strong><br />
•Sexual risk<br />
•Alcohol/drug use<br />
•Medication adherence<br />
•Mental health<br />
MITI cod<strong>in</strong>g to assess counselor’s fidelity to MI<br />
MITI rat<strong>in</strong>g feedback reviewed with counselor<br />
Koken JA. Health Edu Behavior 2012; <strong>in</strong> press
Sexual<br />
Risk<br />
Scores<br />
Mental<br />
health<br />
scores<br />
Pilot Randomized Trial <strong>in</strong> <strong>HIV</strong>+ Thai <strong>Youth</strong> (16-25 y)<br />
MI (Intervention) Health Education (Control)<br />
Basel<strong>in</strong>e 1 M 6 M Basel<strong>in</strong>e 1 M 6 M<br />
4.3±3.6 3.3±3.1 3.4±3.4 3.9±3.5 2.9±2.7 4.3±3.8<br />
P=0.04<br />
1.9±0.3 1.7±0.4 1.7±0.3 1.8±0.5 1.8±0.4 1.7±0.4<br />
P
Thai Healthy Choices: Conclusion<br />
• MI <strong>in</strong>tervention improved sexual risks and mental health<br />
among <strong>HIV</strong>+ Thai youth.<br />
• Its person-centered approach was well accepted by youth.<br />
• Integration of MI-based <strong>in</strong>tervention <strong>in</strong> standard care <strong>for</strong><br />
<strong>HIV</strong>+ youth <strong>in</strong> less-developed countries is feasible and should<br />
be considered.
Acknowledgement<br />
ACKNOWLEDGMENT<br />
<strong>Thailand</strong>: <strong>HIV</strong>NAT<br />
Apirudee Panthong, MA<br />
Sanya Umasa, BA<br />
Thesh<strong>in</strong>ee Chuenyam, RN<br />
Torsak Bunupuradah, MD<br />
Pichai Saengcharnchai, MD<br />
Praphan Phanuphak, MD, PhD<br />
City University of New York<br />
Jul<strong>in</strong>e Koken, PhD<br />
Jeffrey Parsons, PhD<br />
Wayne State University<br />
Sylvie Naar-K<strong>in</strong>g, PhD<br />
Bo Wang, PhD<br />
L<strong>in</strong>da Kaljee, PhD<br />
Kathryn Wright, DO<br />
Bonita Stanton, MD<br />
US NIH